CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 37 enrolled
Drug / intervention
Cognitive Trainingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01550796
NCT01550796Phase 2Completed

Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine

Washington University School of Medicine·interventional·Posted Mar 12, 2012·Updated May 23, 2013

In Brief

A Phase 2 clinical trial evaluating Cognitive Training for Tinnitus. Completed, enrolled 37 participants across 1 site.

Detailed Summary

The purpose of this research study is to determine if a medication along with a computer program designed to improve memory and other mental processes can help people like yourself with tinnitus. The medication that will be investigated, d-cycloserine, was developed as an antibiotic. However, more recently, research in other studies has shown that this medication may enhance learning and memory. The investigators would like to determine if computer programs designed to improve memory and attention are enhanced by this medication. In addition, the investigators hope to learn if the use of these programs can help participants with their tinnitus as well as their ability to remember and focus. All research participants will receive therapy with a computer-based program designed to improve memory and attention. Half of participants will also receive d-cycloserine while the other half of participants will receive placebo. The placebo is a sugar pill without active medication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinnitus
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 12, 2012
Enrollment StartJan 1, 2012
Primary CompletionApr 1, 2012
Study CompletionJun 1, 2012
TodayJul 1, 2026
Enrollment to primary: 3 monthsPosted 14.3 years ago

Interventions

Cognitive Trainingbehavioral

250 mg d-cycloserine or placebo taken orally one hour before Brain Fitness Program